References
- Eckerle LD, Becker MM, Halpin RA, et al. Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing. PLoS Pathog. 2010;6:e1000896.
- Peck KM, Lauring AS. Complexities of viral mutation rates. J Virol. 2018;92; doi:https://doi.org/10.1128/JVI.01031-17.
- Rambaut A, Holmes EC, O’Toole Á, et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat Microbiol. 2020. doi:https://doi.org/10.1038/s41564-020-0770-5
- Rowe CL, Fleming JO, Nathan MJ, et al. Generation of coronavirus spike deletion variants by high-frequency recombination at regions of predicted RNA secondary structure. J Virol. 1997;71:6183–6190.
- Rowe CL, Baker SC, Nathan MJ, et al. Evolution of mouse hepatitis virus: detection and characterization of spike deletion variants during persistent infection. J Virol. 1997;71:2959–2969.
- Muth D, Corman VM, Roth H, et al. Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission. Sci Rep. 2018;8:15177.
- Lau S-Y, Wang P, Mok BW-Y, et al. Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction. Emerg Microbes Infect. 2020;9:837–842.
- Wong YC, Lau SY, Wang To KK, et al. Natural transmission of bat-like SARS-CoV-2 deltaPRRA variants in COVID-19 patients. Clin Infect Dis. 2020. doi:https://doi.org/10.1093/cid/ciaa953
- Young BE, Fong S-W, Chan Y-H, et al. Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study. Lancet. 2020;396:603–611.
- Andrés C, Garcia-Cehic D, Gregori J, et al. Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients. Emerg Microbes Infect. 2020;9:1900–1911.
- Majzoub K, Wrensch F, Baumert TF. The innate antiviral response in animals: an evolutionary perspective from flagellates to humans. Viruses. 2019;11; doi:https://doi.org/10.3390/v11080758.
- Cattaneo R, Schmid A, Eschle D, et al. Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell. 1988;55:255–265.
- Lehmann KA, Bass BL. The importance of internal loops within RNA substrates of ADAR1. J Mol Biol. 1999;291:1–13.
- Samuel CE. ADARs: viruses and innate immunity. Curr Top Microbiol Immunol. 2012;353:163–195.
- Piontkivska H, Matos LF, Paul S, et al. Role of host-driven mutagenesis in determining genome evolution of sigma virus (DMelSV; Rhabdoviridae) in Drosophila melanogaster. Genome Biol Evol. 2016;8:2952–2963.
- Phuphuakrat A, Kraiwong R, Boonarkart C, et al. Double-stranded RNA adenosine deaminases enhance expression of human immunodeficiency virus type 1 proteins. J Virol. 2008;82:10864–10872.
- Tang Y-D, Na L, Fu L-H, et al. Double-stranded RNA-specific adenosine deaminase 1 (ADAR1) promotes EIAV replication and infectivity. Virology. 2015;476:364–371.
- Doria M, Neri F, Gallo A, et al. Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection. Nucleic Acids Res. 2009;37:5848–5858.
- Casey JL. Control of ADAR1 editing of hepatitis delta virus RNAs. Curr Top Microbiol Immunol. 2012;353:123–143.
- Clerzius G, Gélinas J-F, Gatignol A. Multiple levels of PKR inhibition during HIV-1 replication. Rev Med Virol. 2011;21:42–53.
- Wong SK, Lazinski DW. Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1. Proc Natl Acad Sci U S A. 2002;99:15118–15123.
- Rangan R, Zheludev IN, Das R. RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses. bioRxiv Prepr Serv Biol. 2020. doi:https://doi.org/10.1101/2020.03.27.012906
- Di Giorgio S, Martignano F, Torcia MG, et al. Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2. Sci Adv. 2020;6:eabb5813.
- Chen Q, Perales C, Soria ME, et al. Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure. Antiviral Res. 2020;174. doi:https://doi.org/10.1016/j.antiviral.2019.104694.
- Perales C, Chen Q, Soria ME, et al. Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant. Infect Drug Resist. 2018;11:2207–2210.
- Magoc T, Salzberg SL. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics. 2011;27:2957–2963.
- Gregori J, Salicru M, Domingo E, et al. Inference with viral quasispecies diversity indices: clonal and NGS approaches. Bioinformatics. 2014;30; doi:https://doi.org/10.1093/bioinformatics/btt768.
- R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2020.
- Pages H, Aboyoun P, Gentleman R, et al. Biostrings: string objects representing biological sequences, and matching algorithms. R package 2.38.4. 2012.
- Paradis E. Schliep K. ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R. Bioinformatics. 2019;35:526–528.
- Morgan M, Anders S, Lawrence M, et al. Shortread: a bioconductor package for input, quality assessment and exploration of high-throughput sequence data. Bioinformatics. 2009;25:2607–2608.
- Wagih O. Ggseqlogo: a versatile R package for drawing sequence logos. Bioinformatics. 2017;33:3645–3647.
- Gallego I, Gregori J, Soria ME, et al. Resistance of high fitness hepatitis C virus to lethal mutagenesis. Virology. 2018;523:100–109.
- Gregori J, Perales C, Rodriguez-Frias F, et al. Viral quasispecies complexity measures. Virology. 2016;493. doi:https://doi.org/10.1016/j.virol.2016.03.017.
- Gregori J, Soria ME, Gallego I, et al. Rare haplotype load as marker for lethal mutagenesis. PLoS One. 2018;13:e0204877.
- Lehmann KA, Bass BL. Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities. Biochemistry. 2000;39:12875–12884.
- Zuker M, Stiegler P. Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucleic Acids Res. 1981;9:133–148.
- Gruber AR, Lorenz R, Bernhart SH, et al. The Vienna RNA websuite. Nucleic Acids Res. 2008;36:W70–W74.
- Lorenz R, Bernhart SH, Höner Zu Siederdissen C, et al. Vienna RNA package 2.0. Algorith Mol Biol. 2011;6:26.
- Mercatelli D, Giorgi FM. Geographic and genomic distribution of SARS-CoV-2 mutations. Front Microbiol. 2020;11:1800.
- Smith EC, Denison MR. Coronaviruses as DNA wannabes: a new model for the regulation of RNA virus replication fidelity. PLoS Pathog. 2013;9:e1003760.
- Gribble J, Pruijssers AJ, Agostini ML, et al. The coronavirus proofreading exoribonuclease mediates extensive viral recombination. bioRxiv. 2020. doi:https://doi.org/10.1101/2020.04.23.057786
- Tomaselli S, Galeano F, Locatelli F, et al. ADARs and the balance game between virus infection and innate immune cell response. Curr Issues Mol Biol. 2015;17:37–51.
- van Dorp L, Acman M, Richard D, et al. Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. Infect Genet Evol J Mol Epidemiol Evol Genet Infect Dis. 2020;83:104351.
- Shu Y, McCauley J. GISAID: global initiative on sharing all influenza data – from vision to reality. Euro Surveill Bull Eur sur les Mal Transm Eur Commun Dis Bull. 2017;22. doi:https://doi.org/10.2807/1560-7917.ES.2017.22.13.30494.
- Elbe S, Buckland-Merrett G. Data, disease and diplomacy: GISAID’s innovative contribution to global health. Glob Challeng. 2017;1:33–46.
- García-Crespo C, Soria ME, Gallego I, et al. Dissimilar conservation pattern in hepatitis C virus mutant spectra, consensus sequences, and data banks. J Clin Med. 2020;9. doi:https://doi.org/10.3390/jcm9113450.
- Novella IS, Quer J, Domingo E, et al. Exponential fitness gains of RNA virus populations are limited by bottleneck effects. J Virol. 1999;73:1668–1671.
- Kang Y, Chen T, Mui D, et al. Cardiovascular manifestations and treatment considerations in COVID-19. Heart. 2020;106:1132–1141.
- Mapping the human genetic architecture of COVID-19. Nature. 2021. doi:https://doi.org/10.1038/s41586-021-03767-x
- Cattaneo R. Biased (A–>I) hypermutation of animal RNA virus genomes. Curr Opin Genet Dev. 1994;4:895–900.
- George CX, John L, Samuel CE. An RNA editor, adenosine deaminase acting on double-stranded RNA (ADAR1). J Interf Cytokine Res Off J Int Soc Interf Cytokine Res. 2014;34:437–446.
- Martinez MA, Vartanian JP, Wain-Hobson S. Hypermutagenesis of RNA using human immunodeficiency virus type 1 reverse transcriptase and biased dNTP concentrations. Proc Natl Acad Sci USA. 1994;91:11787–11791.
- Martínez MA, Sala M, Vartanian JP, et al. Reverse transcriptase and substrate dependence of the RNA hypermutagenesis reaction. Nucleic Acids Res. 1995;23:2573–2578.
- Carpenter JA, Keegan LP, Wilfert L, et al. Evidence for ADAR-induced hypermutation of the Drosophila sigma virus (Rhabdoviridae). BMC Genet. 2009;10:75.
- Vandelli A, Monti M, Milanetti E, et al. Structural analysis of SARS-CoV-2 genome and predictions of the human interactome. Nucleic Acids Res. 2020;48:11270–11283.